Mesoblast Balance Sheet Health
Financial Health criteria checks 4/6
Mesoblast has a total shareholder equity of $508.7M and total debt of $115.8M, which brings its debt-to-equity ratio to 22.8%. Its total assets and total liabilities are $670.3M and $161.6M respectively.
Key information
22.8%
Debt to equity ratio
US$115.76m
Debt
| Interest coverage ratio | n/a |
| Cash | US$77.55m |
| Equity | US$508.73m |
| Total liabilities | US$161.55m |
| Total assets | US$670.29m |
Financial Position Analysis
Short Term Liabilities: MSB's short term assets ($85.2M) exceed its short term liabilities ($31.4M).
Long Term Liabilities: MSB's short term assets ($85.2M) do not cover its long term liabilities ($130.2M).
Debt to Equity History and Analysis
Debt Level: MSB's net debt to equity ratio (7.5%) is considered satisfactory.
Reducing Debt: MSB's debt to equity ratio has increased from 12.1% to 22.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MSB has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: MSB has sufficient cash runway for 1.4 years if free cash flow continues to grow at historical rates of 0.9% each year.